XML 38 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
3 Months Ended
Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2018 were as follows:
 
Codman Specialty
Surgical
 
Orthopedics and
Tissue Technologies
 
Total
 
(In thousands)
Goodwill at December 31, 2017
$
634,767

 
$
303,138

 
$
937,905

Codman acquisition purchase price allocation adjustments
(2,783
)
 

 
(2,783
)
Foreign currency translation
6,335

 
3,038

 
9,373

Balance, March 31, 2018
$
638,319

 
$
306,176

 
$
944,495

Components of Company's Identifiable Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 
March 31, 2018
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
873,943

 
$
(135,897
)
 
$
738,046

Customer relationships
13 years
 
233,922

 
(95,942
)
 
137,980

Trademarks/brand names
28 years
 
105,187

 
(23,258
)
 
81,929

Codman trade name
Indefinite
 
162,900

 

 
162,900

Supplier relationships
27 years
 
34,721

 
(15,449
)
 
19,272

All other (1)
4 years
 
11,347

 
(3,520
)
 
7,827

 
 
 
$
1,422,020

 
$
(274,066
)
 
$
1,147,954


 
December 31, 2017
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
869,174

 
$
(124,096
)
 
$
745,078

Customer relationships
13 years
 
233,430

 
(91,961
)
 
141,469

Trademarks/brand names
28 years
 
104,879

 
(22,293
)
 
82,586

Codman trade name
Indefinite
 
162,900

 

 
162,900

Supplier relationships
27 years
 
34,721

 
(15,092
)
 
19,629

All other (1)
4 years
 
11,511

 
(3,546
)
 
7,965

 
 
 
$
1,416,615

 
$
(256,988
)
 
$
1,159,627

 
(1) 
At March 31, 2018 and December 31, 2017, all other included in-process research and development ("IPR&D") costs of $1.0 million in both periods, which was indefinite-lived.